{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:59:01Z","timestamp":1792803541250,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ophtha.2019.05.016","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T20:58:23Z","timestamp":1559077103000},"page":"1667-1674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study"],"prefix":"10.1016","volume":"126","author":[{"given":"Marco","family":"Nassisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar Saleh","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Karamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Uji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Marion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Morgenthien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2019.05.016_bib1","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archopht.121.11.1621","article-title":"Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11","volume":"121","author":"Bressler","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2019.05.016_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A\u00a0randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.05.016_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0161-6420(97)30368-6","article-title":"The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study","volume":"104","author":"Klein","year":"1997","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2019.05.016_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/IAE.0b013e318074c290","article-title":"Iron toxicity as a potential factor in AMD","volume":"27","author":"Wong","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2019.05.016_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000438954","article-title":"Emixustat and lampalizumab: potential therapeutic options for geographic atrophy","volume":"55","author":"Jack","year":"2016","journal-title":"Dev Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2019.05.016_bib6","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.ophtha.2013.05.029","article-title":"Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration","volume":"120","author":"Ouyang","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2019.05.016_bib7","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1167\/iovs.18-24143","article-title":"Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression","volume":"59","author":"Nassisi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2019.05.016_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ophtha.2015.10.029","article-title":"Reticular pseudodrusen and their association with age-related macular degeneration: the Melbourne Collaborative Cohort Study","volume":"123","author":"Finger","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2019.05.016_bib9","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1167\/iovs.12-11073","article-title":"Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration","volume":"54","author":"Marsiglia","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2019.05.016_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2016.02.043","article-title":"Pseudodrusen and incidence of late age-related macular degeneration in fellow eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"123","author":"Zhou","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2019.05.016_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.survophthal.2018.05.005","article-title":"Subretinal drusenoid deposits AKA pseudodrusen","volume":"63","author":"Spaide","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2019.05.016_bib12","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1167\/iovs.15-18572","article-title":"Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye","volume":"57","author":"Abdelfattah","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2019.05.016_bib13","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00417-017-3693-y","article-title":"Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration","volume":"255","author":"Lei","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.05.016_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ophtha.2012.10.014","article-title":"Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration","volume":"120","author":"Busbee","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ophtha.2019.05.016_bib15","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ophtha.2014.05.009","article-title":"Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration","volume":"121","author":"Ho","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.05.016_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2019.05.016_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1167\/iovs.11-8188","article-title":"Automated characterization of pigment epithelial detachment by optical coherence tomography","volume":"53","author":"Lee","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2019.05.016_bib18","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1097\/IAE.0000000000000932","article-title":"Diagnosis of type 3 neovascularization based on optical coherence tomography images","volume":"36","author":"Kim","year":"2016","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ophtha.2019.05.016_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","article-title":"The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration","volume":"158","author":"Jung","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.05.016_bib20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ophtha.2012.07.004","article-title":"Spectral-domain optical coherence tomography characteristics of intermediate\u00a0age-related macular degeneration","volume":"120","author":"Leuschen","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2019.05.016_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/IAE.0000000000000488","article-title":"Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography","volume":"35","author":"Nagiel","year":"2015","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.ophtha.2019.05.016_bib22","doi-asserted-by":"crossref","first-page":"7093","DOI":"10.1167\/iovs.14-14918","article-title":"Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression","volume":"55","author":"de Sisternes","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ophtha.2019.05.016_bib23","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.ophtha.2013.03.017","article-title":"Incidence of choroidal neovascularization in the fellow eye in the comparison of age-related macular degeneration treatments trials","volume":"120","author":"Maguire","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2019.05.016_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ajo.2010.01.007","article-title":"Incidence of new choroidal neovascularization in fellow eyes of patients treated in the MARINA and ANCHOR Trials","volume":"149","author":"Barbazetto","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2019.05.016_bib25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","article-title":"Optical coherence tomography\u2013defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019302908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019302908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:26Z","timestamp":1758982046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019302908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0161642019302908"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.05.016","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}